maltose
Small moleculeexperimental
Maltose, also known as maltobiose or malt sugar, is a disaccharide formed from two units of glucose joined with an α(1→4) bond. In the isomer isomaltose, the two glucose molecules are joined with an α(1→6) bond. Maltose is the two-unit member of the amylose homologous series, the key structural motif of starch. When beta-amylase breaks down starch, it removes two glucose units at a time, producing maltose. An example of this reaction is found in germinating seeds, which is why it was named after malt. Unlike sucrose, it is a reducing sugar. — Wikipedia
Clinical trial activity
9 trials · 25 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT01146535)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O- Mol. weight
- 342.3 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaMaltose ↗
- ChEMBLCHEMBL1908365 ↗
Also known as
- d-maltose
- d-(+)-maltose
- d-(+)-maltose
- maltobiose
- maltose
- maltose
- maltose
- maltose
- maltose
- maltose
- maltose
- maltose
- maltose anhydrous
- maltose anhydrous
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07081802 | N/A | Aug 1, 2025 | China Academy of Chinese Medical Sciences, Dalian Medical University, Handan Central Hospital, Hebei University, Nanchang University, The First Hospital of Qinhuangdao |
| NCT06133530 | N/A | Sep 24, 2023 | Chr Hansen, DLR German Aerospace Center, European Space Agency, IU University of Applied Sciences, NASA, University of Bologna, University of Bonn, University of Lorraine |
| NCT05467605 | N/A | Jul 31, 2022 | Cairo University |
| NCT04399265 | Early Phase 1 (Phase 1) | Mar 2, 2020 | National University of Malaysia |
| NCT04505800 | N/A | Sep 1, 2019 | National Yang-Ming University |
| NCT02903030 | Early Phase 1 (Phase 1) | Aug 1, 2016 | Autism Speaks, Autism Treatment Network, Ohio State University |
| NCT02800161 | Phase 3 | Jun 1, 2016 | Centro de Investigación Biomédica en Red (CIBER), Stanley Medical Research Institute |
| NCT01562626 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2012 | Anaeropharma Science, Inc. |
| NCT01146535 | Phase 2 | Jan 1, 2011 | Amarillo Biosciences, Inc., CytoPharm, Inc. |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (25)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amarillo Biosciences, Inc. | For profit | 1 | 1 | 1 | 2011 |
| Anaeropharma Science, Inc. | For profit | 1 | 1 | 1 | 2012 |
| Autism Speaks | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Autism Treatment Network | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Centro de Investigación Biomédica en Red (CIBER) | Academic/Hospital | 1 | 1 | 1 | 2016 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Chr Hansen | For profit | 1 | 0 | 1 | 2023 |
| CytoPharm, Inc. | For profit | 1 | 0 | 1 | 2011 |
| Dalian Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| DLR German Aerospace Center | Academic/Hospital | 1 | 0 | 1 | 2023 |
| European Space Agency | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Handan Central Hospital | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Hebei University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| IU University of Applied Sciences | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| NASA | Government | 1 | 0 | 1 | 2023 |
| National University of Malaysia | Academic/Hospital | 1 | 1 | 1 | 2020 |
| National Yang-Ming University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Ohio State University | Academic/Hospital | 1 | 1 | 1 | 2016 |
25 organizations
Page 1 / 2